Long-acting muscarinic M3 receptor antagonists -: GlaxoSmithKline

被引：5
|
作者：
Norman, Peter [1 ]
机构：
[1] Norman Consulting, Burnham SL1 8JW, Bucks, England
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2006年 / 16卷 / 09期
关键词：
bronchodilator; COPD; M-3; receptor; muscarinic antagonist; urinary incontinence;
D O I：
10.1517/13543776.16.9.1315
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Two applications claim a novel class of muscarinic M-3 receptor antagonists and their use as long-acting agents for the treatment of chronic obstructive pulmonary disease. The two applications claim closely related structures with one claiming quaternary amine salts of the tertiary amines claimed in the other. The claimed compounds comprise a biarylmethylamine core with the amino group modified by acylation or sulfonation and a tertiary or quaternary amine coupled to the distal ring of the biaryl system.
引用
收藏
页码：1315 / 1320
页数：6
相关论文
共 50 条
  • [1] Long-acting muscarinic M3 receptor antagonists -: Theravance
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (09) : 1321 - 1326
  • [2] Discovery of long acting inhaled muscarinic M3 receptor antagonists
    Baettig, Urs
    Collingwood, Steve
    Janus, Diana
    Devereux, Nick
    Stanley, Emily
    Cox, Brian
    McCarthy, Clive
    Charlton, Steven
    Leighton-Davis, Juliette
    Fozard, John R.
    Baur, Francois
    Farr, Dave
    Mazzoni, Lazzaro
    Patel, Viral
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 750 - 750
  • [3] MEDI 286-Discovery of long acting inhaled muscarinic M3 receptor antagonists
    Dankulich, William P.
    Mitchell, Helen J.
    Hartman, George D.
    Meissner, Robert S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 866 - 866
  • [4] Long-acting muscarinic antagonists
    Melani, Andrea S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (04) : 479 - 501
  • [5] Long-acting muscarinic receptor antagonists for the treatment of respiratory disease
    Cazzola, Mario
    Page, Clive
    Matera, Maria Gabriella
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2013, 26 (03) : 307 - 317
  • [6] Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD
    Cazzola, Mario
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (05) : 482 - 490
  • [7] Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases
    Alagha, Khuder
    Palot, Alain
    Sofalvi, Tunde
    Pahus, Laurie
    Gouitaa, Marion
    Tummino, Celine
    Martinez, Stephanie
    Charpin, Denis
    Bourdin, Arnaud
    Chanez, Pascal
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2014, 5 (02) : 85 - 98
  • [8] Novel long-acting antagonists of muscarinic ACh receptors
    Randakova, Alena
    Rudajev, Vladimir
    Dolezal, Vladimir
    Boulos, John
    Jakubik, Jan
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (10) : 1731 - 1743
  • [9] Current long-acting muscarinic antagonists for the treatment of asthma
    Ora, Josuel
    Calzetta, Luigino
    Ritondo, Beatrice Ludovica
    Matera, Maria Gabriella
    Rogliani, Paola
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (17) : 2343 - 2357
  • [10] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma
    Aalbers, Rene
    Park, Hae-Sim
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2017, 9 (05) : 386 - 393
12345